NanoViricides
NNVC
#10077
Rank
NZ$43.96 M
Marketcap
NZ$2.04
Share price
-0.83%
Change (1 day)
-23.77%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.04. In 2024 the company made an earnings per share (EPS) of NZ-$1.20 an increase over its 2023 EPS that were of NZ-$1.27.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.03-14.09%
2024NZ-$1.20-5.41%
2023NZ-$1.275.71%
2022NZ-$1.20-13.58%
2021NZ-$1.39-66.11%
2020NZ-$4.091.7%
2019NZ-$4.03-10.98%
2018NZ-$4.52-22.35%
2017NZ-$5.82-10.53%
2016NZ-$6.51375%
2015NZ-$1.37-85.19%
2014NZ-$9.2542.11%
2013NZ-$6.5126.67%
2012NZ-$5.14-6.25%
2011NZ-$5.4814.28%
2010NZ-$4.80100%
2009NZ-$2.40-0%
2008NZ-$2.40-33.33%
2007NZ-$3.60-0%
2006NZ-$3.604445.07%
2005NZ-$0.07915

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ-$0.08565-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$3.63-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.17-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.09-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.01-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.16-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK